Hair multiplication, or hair cloning, is a process in which dermal papilla cells are taken from hair follicles, multiplied in the lab and injected into the scalp. Researchers believe that this technique could be the most effective in treating hair loss in both men and women.

Hair multiplication is currently developed by Intercytex, a UK-based biotechnology company and is called ICX-TRC.

ICX-TRC overcomes one of the principal drawbacks of conventional transplants which is that the outcome is limited by the amount of donor hair available. By using the Intercytex cell therapy technique almost limitless hair regeneration is possible in a less invasive procedure. Furthermore, treatment can commence early on in the hair loss process with retreatment available in subsequent years. The barrier to commercial success for ICX-TRC is relatively low, being the ability to increase hair count in transplanted or thinning areas.

However, Intercytex had backed out of the tests and wished to continue the development of ICX-TRC in partnership with a specialist in the aesthetics field. Bosley, the largest chain of hair transplant clinics in the US, was given the option to negotiate distribution rights to the product.

We will have to wait for a couple of years more before this technique is available to all of us.

Related: Organin hair loss treatment?, Hair multiplication, Hair cloning, saw palmetto hair loss, vitamins for hair loss.